Xspray Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	197.98	208.24	166.3	120.17	271.88	325.6
Cash & Short-Term Investments	197.98	208.24	166.3	120.17	271.88	325.6
Cash Growth	164.83%	25.21%	38.39%	-55.80%	-16.50%	55.14%
Other Receivables	4.65	4.02	4.17	2.59	2.5	3.32
Receivables	4.65	4.02	4.17	2.59	2.5	3.32
Inventory	27.46	20.34	43.78	8.55	6.2	-
Prepaid Expenses	4.12	2.48	3.57	0.93	1.48	2.1
Other Current Assets	-	0	-	-0	-0	-
Total Current Assets	234.21	235.07	217.82	132.23	282.07	331.02
Property, Plant & Equipment	73.03	79.18	107.65	64.6	44.6	42.67
Long-Term Investments	0	0	0	0	0	0
Long-Term Deferred Charges	509.71	478.93	436.78	385.6	296.24	231.62
Other Long-Term Assets	3.25	3.17	3.02	3	-	-
Total Assets	820.2	796.34	765.26	585.43	622.9	605.3
Accounts Payable	13.42	17.08	12.47	14.79	16.87	8.44
Accrued Expenses	12.68	18.63	16.31	11.41	10.3	8.54
Short-Term Debt	-	96	-	-	-	-
Current Portion of Leases	5.31	5.11	4.86	1.57	2.05	1.99
Other Current Liabilities	3.46	9.31	6.26	1.09	0.75	0.86
Total Current Liabilities	34.86	146.14	39.9	28.85	29.97	19.82
Long-Term Leases	23.08	27.11	31.95	0.56	1.19	2.9
Other Long-Term Liabilities	120.53	-0	-	-	-	-
Total Liabilities	178.47	173.25	71.85	29.41	31.15	22.72
Common Stock	41.74	37.14	31.25	22.68	20.68	18.89
Additional Paid-In Capital	1,574	1,425	1,216	907.42	813.48	709.41
Retained Earnings	-974.7	-840.25	-554.72	-374.08	-242.41	-145.71
Comprehensive Income & Other	0.64	1	0.79	-	-	-
Shareholders' Equity	641.73	623.1	693.41	556.02	591.75	582.59
Total Liabilities & Equity	820.2	796.34	765.26	585.43	622.9	605.3
Total Debt	28.39	128.22	36.81	2.13	3.23	4.88
Net Cash (Debt)	169.6	80.02	129.5	118.04	268.65	320.72
Net Cash Growth	312.11%	-38.21%	9.70%	-56.06%	-16.23%	56.80%
Net Cash Per Share	4.62	2.41	4.87	5.60	13.96	18.63
Filing Date Shares Outstanding	41.74	37.14	31.25	22.68	20.68	18.89
Total Common Shares Outstanding	41.74	37.14	31.25	22.68	20.68	18.89
Working Capital	199.35	88.93	177.91	103.38	252.1	311.2
Book Value Per Share	15.37	16.78	22.19	24.52	28.61	30.84
Tangible Book Value	641.73	623.1	693.41	556.02	591.75	582.59
Tangible Book Value Per Share	15.37	16.78	22.19	24.52	28.61	30.84
Machinery	-	51.5	52.12	49.82	46.96	39.87
Construction In Progress	-	41.39	59.37	46.57	20.04	15.75

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.